Australia Stock Exchange release from DIMERIX : Phase 3 DMX-200 COVID-19 Study Expands into Australia
15/10/2021 24:00
Australia Stock Exchange release from DIMERIX DXB.AX : Phase 3 DMX-200 COVID-19 Study Expands into Australia
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions